Parkman Healthcare Partners LLC Moderna, Inc. Transaction History

Parkman Healthcare Partners LLC

  • $687 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$54.34 - $94.85 $543,400 - $948,500
-10,000 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$29.67 - $80.0 $1.93 Million - $5.2 Million
-65,000 Reduced 86.67%
10,000 $642,000
Q1 2020

May 15, 2020
BUY
$17.78 - $31.58 $1.33 Million - $2.37 Million
75,000 New
75,000 $2.25 Million

Others Institutions Holding MRNA

# of Institutions
917
Shares Held
255M
Call Options Held
19.2M
Put Options Held
24.7M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email